Andreadi, C., Cheung, L., Giblett, S., Patel, B., Jin, H., Mercer, K., . . . Pritchard, C. (2012). The intermediate-activity (L597V)BRAF mutant acts as an epistatic modifier of oncogenic RAS by enhancing signaling through the RAF/MEK/ERK pathway. Cold Spring Harbor Laboratory Press.
Style de citation ChicagoAndreadi, Catherine, et al. The Intermediate-activity (L597V)BRAF Mutant Acts As an Epistatic Modifier of Oncogenic RAS By Enhancing Signaling Through the RAF/MEK/ERK Pathway. Cold Spring Harbor Laboratory Press, 2012.
Style de citation MLAAndreadi, Catherine, et al. The Intermediate-activity (L597V)BRAF Mutant Acts As an Epistatic Modifier of Oncogenic RAS By Enhancing Signaling Through the RAF/MEK/ERK Pathway. Cold Spring Harbor Laboratory Press, 2012.